These results, together with the evidence that mice expressing mutant GluN2A with a Tyr-1325-Phe mutation that prevents its phosphorylation show antidepressant-like behaviour [34], provide support to the notion that NMDA receptor phosphorylation and downstream signalling can modulate depression-related behaviour. Here, GRIN2A is linked to major depressive disorder.